Article Information
History
- September 27, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Xinhua Chen, MPH1,*,
- Wei Wang, PhD1,*,
- Xinghui Chen, BSc1,
- Qianhui Wu, MPH1,
- Ruijia Sun, BSc1,
- Shijia Ge, BSc1,
- Nan Zheng, BSc1,
- Wanying Lu, BSc1,
- Juan Yang, PhD1,
- Lance Rodewald, M.D.2 and
- Hongjie Yu, PhD1,†
- 1School of Public Health, Fudan University, Key Laboratory of Public Health Safety, Ministry of Education, Shanghai, China
- 2National Immunization Programme, Chinese Center for Disease Control and Prevention, Beijing, China
- ↵†Corresponding author: Hongjie Yu, Fudan University, School of Public Health, Key Laboratory of Public Health Safety, Ministry of Education, Shanghai 200032, China; E-mail: yhj{at}fudan.edu.cn
↵* These authors are co-first authors contributed equally to this work.
Posted September 27, 2021.
Prediction of long-term kinetics of vaccine-elicited neutralizing antibody and time-varying vaccine-specific efficacy against the SARS-CoV-2 Delta variant by clinical endpoint
